Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  Marchesan, Julie Teresa ^a   Gerow, Elizabeth Ann ^a   Schaff, Riley ^a   Taut, Andrei Dan ^a   Shin, Seung Yun ^a,b   Sugai, James ^a   Brand, David ^c   Burberry, Aaron ^d   Jorns, Julie ^d   Lundy, Steven Karl ^d   Nuñez, Gabriel ^d   Fox, David A ^d   Giannobile, William V ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b Kyung Hee University   (South Korea)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGEN TYPE 2; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE EROSION; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EMULSION; GENE EXPRESSION; GINGIVA; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MOUTH INFECTION; NONHUMAN; OSTEOCLAST; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; SPLEEN CELL; SWELLING; SYNOVITIS; TH1 CELL; TH17 CELL; ANIMAL; BACTEROIDACEAE INFECTION; BLOOD; DBA MOUSE; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BACTEROIDACEAE INFECTIONS; CYTOKINES; MALE; MICE; MICE, INBRED DBA; PORPHYROMONAS GINGIVALIS;

EID: 84887309767     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4376     Document Type: Article

References (53)

1. Albandar JM. Underestimation of periodontitis in NHANES surveys. J Periodontol 2011, 82:337-341. 10.1902/jop.2011.100638, 21214340.
2. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol 2012, 10:717-725. 10.1038/nrmicro2873, 3498498, 22941505.
3. Socransky SS, Smith C, Haffajee AD. Subgingival microbial profiles in refractory periodontal disease. J Clin Periodontol 2002, 29:260-268. 10.1034/j.1600-051x.2002.290313.x, 11940147.
4. Burns E, Bachrach G, Shapira L, Nussbaum G. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 2006, 177:8296-8300.
5. Gaddis DE, Michalek SM, Katz J. TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B. J Immunol 2011, 186:5772-5783. 10.4049/jimmunol.1003192, 3809913, 21498664.
6. Chung WO, An JY, Yin L, Hacker BM, Rohani MG, Dommisch H, DiJulio DH. Interplay of protease-activated receptors and NOD pattern recognition receptors in epithelial innate immune responses to bacteria. Immunol Lett 2010, 131:113-119. 10.1016/j.imlet.2010.02.006, 2885501, 20219537.
7. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010, 89:1349-1363. 10.1177/0022034510376402, 20739705.
8. Yu JJ, Ruddy MJ, Conti HR, Boonanantanasarn K, Gaffen SL. The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun 2008, 76:4206-4213. 10.1128/IAI.01209-07, 2519446, 18591228.
9. Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S, Ciero PA, Krauss JL, Li F, Rauner M, Hofbauer LC, Choi EY, Chung KJ, Hashim A, Curtis MA, Chavakis T, Hajishengallis G. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol 2012, 13:465-473. 10.1038/ni.2260, 3330141, 22447028.
10. Marchesan JT, Morelli T, Lundy SK, Jiao Y, Lim S, Inohara N, Nunez G, Fox DA, Giannobile WV. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis. Mol Oral Microbiol 2012, 27:483-495. 10.1111/omi.12001, 23134613.
11. Miyauchi S, Maekawa T, Aoki Y, Miyazawa H, Tabeta K, Nakajima T, Yamazaki K. Oral infection with Porphyromonas gingivalis and systemic cytokine profile in C57BL/6.KOR-ApoE shl mice. J Periodontal Res 2012, 47:402-408. 10.1111/j.1600-0765.2011.01441.x, 22097957.
12. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 2009, 104:59-68. 10.1016/j.amjcard.2009.05.002, 19576322.
13. Lamster IB, Lalla E, Borgnakke WS, Taylor GW. The relationship between oral health and diabetes mellitus. J Am Dent Assoc 2008, 139:19S-24S.
14. de Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008, 35:70-76.
15. Brooks PM. The burden of musculoskeletal disease - a global perspective. Clin Rheumatol 2006, 25:778-781. 10.1007/s10067-006-0240-3, 16609823.
16. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442. 10.1038/nri2094, 17525752.
17. Mirrielees J, Crofford LJ, Lin Y, Kryscio RJ, Dawson DR, Ebersole JL, Miller CS. Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol 2010, 37:1068-1074. 10.1111/j.1600-051X.2010.01625.x, 2980566, 20880053.
18. Cornelissen F, Asmawidjaja PS, Mus AM, Corneth O, Kikly K, Lubberts E. IL-23 dependent and independent stages of experimental arthritis: no clinical effect of therapeutic IL-23p19 inhibition in collagen-induced arthritis. PLoS One 2013, 8:e57553. 10.1371/journal.pone.0057553, 3585376, 23469022.
19. Marijnissen RJ, Koenders MI, Smeets RL, Stappers MH, Nickerson-Nutter C, Joosten LA, Boots AM, van den Berg WB. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum 2011, 63:2939-2948. 10.1002/art.30469, 21618207.
20. Sarkar S, Zhou X, Justa S, Bommireddy SR. Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. Arthritis Rheum 2013, 65:960-971. 10.1002/art.37849, 23334981.
21. Chen HH, Huang N, Chen YM, Chen TJ, Chou P, Lee YL, Chou YJ, Lan JL, Lai KL, Lin CH, Chen DY. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis 2012, 72:1206-1211.
22. Mikuls TR, Thiele GM, Deane KD, Payne JB, O'Dell JR, Yu F, Sayles H, Weisman MH, Gregersen PK, Buckner JH, Keating RM, Derber LA, Robinson WH, Holers VM, Norris JM. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012, 64:3522-3530. 10.1002/art.34595, 3467347, 22736291.
23. Erciyas K, Sezer U, Ustun K, Pehlivan Y, Kisacik B, Senyurt S, Tarakcioglu M, Onat A. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis 2012, 19:394-400.
24. Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, Askari A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009, 80:535-540. 10.1902/jop.2009.080447, 2884010, 19335072.
25. Al-Katma MK, Bissada NF, Bordeaux JM, Sue J, Askari AD. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 2007, 13:134-137. 10.1097/RHU.0b013e3180690616, 17551378.
26. Ogrendik M. Rheumatoid arthritis is linked to oral bacteria: etiological association. Mod Rheumatol 2009, 19:453-456. 10.1007/s10165-009-0194-9, 19554393.
27. Cantley MD, Haynes DR, Marino V, Bartold PM. Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. J Clin Periodontol 2011, 38:532-541. 10.1111/j.1600-051X.2011.01714.x, 21434962.
28. Kobayashi R, Kono T, Bolerjack BA, Fukuyama Y, Gilbert RS, Fujihashi K, Ruby J, Kataoka K, Wada M, Yamamoto M, Fujihashi K. Induction of IL-10-producing CD4+ T-cells in chronic periodontitis. J Dent Res 2011, 90:653-658. 10.1177/0022034510397838, 3144111, 21335536.
29. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc 2007, 2:1269-1275. 10.1038/nprot.2007.173, 17546023.
30. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, Wasco MJ, Fox DA. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 2009, 11:R158. 10.1186/ar2838, 2787258, 19852819.
31. Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD. Collagen-induced arthritis. Curr Protoc Immunol 2010, Chapter 15. Unit 15.5.1-25.
32. Park CH, Abramson ZR, Taba M, Jin Q, Chang J, Kreider JM, Goldstein SA, Giannobile WV. Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol 2007, 78:273-281. 10.1902/jop.2007.060252, 2581750, 17274716.
33. Schett G, Tuerk B. Bone histomorphometry in arthritis models. Methods Mol Med 2007, 135:269-283. 10.1007/978-1-59745-401-8_17, 17951665.
34. Barck KH, Lee WP, Diehl LJ, Ross J, Gribling P, Zhang Y, Nguyen K, van Bruggen N, Hurst S, Carano RA. Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis. Arthritis Rheum 2004, 50:3377-3386. 10.1002/art.20557, 15476252.
35. Boabaid F, Berry JE, Koh AJ, Somerman MJ, McCcauley LK. The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. J Periodontol 2004, 75:1247-1254. 10.1902/jop.2004.75.9.1247, 15515341.
36. Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Schols D, De Wolf-Peeters C, Billiau A. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J Immunol 1999, 163:3503-3510.
37. Song X, Shen J, Wen H, Zhong Z, Luo Q, Chu D, Qi Y, Xu Y, Wei W. Impact of Schistosoma japonicum infection on collagen-induced arthritis in DBA/1 mice: a murine model of human rheumatoid arthritis. PLoS One 2011, 6:e23453. 10.1371/journal.pone.0023453, 3152573, 21858123.
38. Taurog JD, Leary SL, Cremer MA, Mahowald ML, Sandberg GP, Manning PJ. Infection with Mycoplasma pulmonis modulates adjuvant- and collagen-induced arthritis in Lewis rats. Arthritis Rheum 1984, 27:943-946. 10.1002/art.1780270816, 6331830.
39. Pineda MA, McGrath MA, Smith PC, Al-Riyami L, Rzepecka J, Gracie JA, Harnett W, Harnett MM. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites. Arthritis Rheum 2012, 64:3168-3178. 10.1002/art.34581, 22729944.
40. Ellis JS, Chain BM, Cooke A, Ibrahim MA, Katz DR. Adjuvant composition determines the induction of type II collagen-induced arthritis. Scand J Immunol 1992, 36:49-56. 10.1111/j.1365-3083.1992.tb02939.x, 1615283.
41. Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 1996, 26:2399-2403. 10.1002/eji.1830261020, 8898952.
42. Jung S, Park YK, Lee H, Shin JH, Lee GR, Park SH. TGF-beta-treated antigen presenting cells suppress collagen-induced arthritis through the promotion of Th2 responses. Exp Mol Med 2010, 42:187-194. 10.3858/emm.2010.42.3.019, 2845003, 20164680.
43. Takayanagi H. New immune connections in osteoclast formation. Ann N Y Acad Sci 2010, 1192:117-123. 10.1111/j.1749-6632.2009.05303.x, 20392226.
44. Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC, Becher B. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J Immunol 2007, 179:8098-8104.
45. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852. 10.1146/annurev.immunol.25.022106.141557, 17201677.
46. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240. 10.1084/jem.20041257, 2212798, 15657292.
47. Trombone AP, Claudino M, Colavite P, de Assis GF, Avila-Campos MJ, Silva JS, Campanelli AP, Ibanez OM, De Franco M, Garlet GP. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes Immun 2010, 11:479-489. 10.1038/gene.2010.13, 20428191.
48. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 2008, 35:89-105. 10.1111/j.1600-051X.2007.01172.x, 2649707, 18199146.
49. Park JC, Su C, Jung IH, Choi SH, Cho KS, Kim CK, Park YB, Lee SK, Kim CS. Mechanism of alveolar bone loss in a collagen-induced arthritis model in mice. J Clin Periodontol 2011, 38:122-130. 10.1111/j.1600-051X.2010.01645.x, 21062340.
50. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 2005, 76:229-233. 10.1902/jop.2005.76.2.229, 15974846.
51. Queiroz-Junior CM, Madeira MF, Coelho FM, Costa VV, Bessoni RL, Sousa LF, Garlet GP, Souza Dda G, Teixeira MM, Silva TA. Experimental arthritis triggers periodontal disease in mice: involvement of TNF-alpha and the oral microbiota. J Immunol 2011, 187:3821-3830. 10.4049/jimmunol.1101195, 21890656.
52. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012, 64:3083-3094. 10.1002/art.34539, 3428472, 22576262.
53. Smit MD, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 2012, 14:R222. 10.1186/ar4061, 3580533, 23075462.